The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes.

Thomas, Merlin C; Coughlan, Melinda T; Cooper, Mark E

Thomas, Merlin C; Coughlan, Melinda T; Cooper, Mark E.

Afiliação

Thomas MC; Department of Diabetes, Monash University, Central Clinical School, 99 Commercial Road, Melbourne, Australia; Department of Biochemistry, Monash University, Melbourne, Australia.
Coughlan MT; Department of Diabetes, Monash University, Central Clinical School, 99 Commercial Road, Melbourne, Australia; Drug Discovery Biology, Monash Institute of Pharmaceutical Science, Monash University Parkville Campus, 381 Royal Parade, Parkville, 3052 VIC, Australia.
Cooper ME; Department of Diabetes, Monash University, Central Clinical School, 99 Commercial Road, Melbourne, Australia. Electronic address: mark.cooper@monash.edu.

Cell Metab ; 35(2): 253-273, 2023 02 07.

Article em En | MEDLINE | ID: mdl-36754019

Assuntos

Sistema Cardiovascular; Diabetes Mellitus Tipo 2; Receptor do Peptídeo Semelhante ao Glucagon 1; Humanos; Diabetes Mellitus Tipo 2/complicações; Diabetes Mellitus Tipo 2/tratamento farmacológico; Receptor do Peptídeo Semelhante ao Glucagon 1/agonistas; Hipoglicemiantes/uso terapêutico; Rim

Palavras-chave

GLP-1 receptor; GLP-1 receptor agonist; cardioprotection; cardiovascular outcomes; diabetic complications; glucagon-like peptide-1; major acute cardiovascular event; renoprotection; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Diabetes Mellitus Tipo 2 / Receptor do Peptídeo Semelhante ao Glucagon 1 Limite: Humans Idioma: En Revista: Cell Metab Assunto da revista: METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google